A prospective study on the prevalence of MASLD in people with type-2 diabetes in the community. Cost effectiveness of screening strategies.
Roberta ForlanoTijana StanicSahan JayawardanaBenjamin Harvey MullishMichael YeeElias MossialosRobert GoldinSalvatore PettaEmmanuel A TsochatzisMark ThurszPinelopi ManousouPublished in: Liver international : official journal of the International Association for the Study of the Liver (2023)
Screening for MASLD in the diabetic population in primary care is cost-effective and should become part of a holistic assessment. However, traditional screening strategies, including FIB-4 and ELF, underestimate the presence of significant liver disease in this setting.